Alfonso L. Sabater, MD, PhD, of the Bascom Palmer Eye Institute, spoke with Ophthalmology 360 at the American Society of Cataract and Refractive Surgery Annual Meeting about the launch of Ocubio’s qualified autologous serum eye drops. Dr. Sabater is a founder and the Chief Vision Officer of Ocubio. Learn more at Ocubio.com.
Alfonso L. Sabater, MD, PhD:
My name is Alfonso Sabater. I’m an Associate Professor of Clinical Ophthalmology at the Bascom Palmer Eye Institute and also the founder and Chief Vision Officer of Ocubio. We are a Bascom Palmer Eye Institute spin-off company.
We are here during ASCRS launching the company, but also launching our first product, qualified autologous serum eye drops, which have been validated for use of room temperature. We have other products in the pipeline that we’re excited about, and I welcome you to visit our website at ocubio.com to learn more about our products and also about what it’s coming in the future. We’re very excited about this project.
Related Content
